A Review of the Scientific Literature As It Pertains to Gulf War Illnesses
Pyridostigmine Bromide, Executive Summary
The United States and its allies in the Persian Gulf War (PGW) knew that Iraq had used nerve agents and chemical weapons in its previous conflicts and so took steps to protect their troops. Pyridostigmine bromide (PB) was distributed as a pretreatment that would enhance the effectiveness of postexposure treatments in the event that the nerve agent soman was used. This report examines the role that PB played in the ongoing chronic health problems documented in PGW veterans. After careful examination of the known effects of PB on the central and peripheral nervous systems, the author finds the evidence consistent with a possible role for PB as a contributor to the health complaints of PGW veterans and calls for immediate attention in the form of additional investigation to clarify the role of PB.
- Format:
- Paperback, 24 Pages
- Year:
- 1999
- List Price:
- $7.50
- Price:
- $6.00 Special 20% Web Discount
- Full Document (pdf format)
Use Adobe Acrobat Reader version 7.0 or higher for the best experience.
Document Details
- Copyright: RAND Corporation
- Availability: Available
- Format: Paperback
- Pages: 24
- List Price: $7.50
- Price: $6.00
- ISBN/EAN: 0-8330-2795-6
- Document Number: MR-1018/2-1-OSD
- Year: 1999
- Series: Monograph Reports
This research was sponsored by RAND's National Security Research Division and RAND Health.
This report is part of the RAND Corporation monograph report series. The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
RAND® is a registered trademark. Copyright © 1994-2012 RAND Corporation.